GA HB1296

Creates the "Breakthrough Treatments for Georgia Heroes Suicide Prevention Pilot Program," a three-year pilot beginning January 1, 2027, to provide eligible breakthrough treatments to veterans and retired first responders suffering from PTSD, treatment-resistant depression, major depressive disorder, and traumatic brain injury

Eligible breakthrough treatments include FDA-designated breakthrough devices and drugs, ibogaine-based therapeutics, transcranial magnetic stimulation, and other substantially similar investigational treatments approved by the department

Program funds may establish a network of approved treatment sites across diverse geographic regions, conduct clinical research and trials, subsidize treatment costs, invest in clinical infrastructure in underserved areas, and provide healthcare workforce training

Department of Behavioral Health and Developmental Disabilities may partner with Georgia postsecondary research institutions accredited by SACS and must submit annual reports by December 31 to the Governor and relevant legislative committees

Program terminates and the code section automatically repeals on January 1, 2030; the Act only becomes effective if funds are specifically appropriated by the General Assembly